Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

114.87

-1.25 (1.08%)

as of Jun 9, 2026, 8:00:00 pm Market Open.

214 watching

Investor Insights

Jun 9, 2026, 12:00 am

This summary was created by AI, based on 32 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) continues to evoke mixed opinions from experts, with many emphasizing its valuable proprietary data, especially for legal and accounting sectors. Some analysts recognize its potential to leverage AI technologies to enhance efficiency and product offerings. However, concerns around valuation persist, particularly with the stock's historical high PE ratios and recent downward trends. While there are varying perspectives on how AI may disrupt its core business, some analysts see TRI's unique data moat as a strong competitive advantage that may help it maintain resilience. Overall, while there are advocates for its long-term potential, there are also cautionary notes regarding its current market assessment and future revenue impacts from technological advancements.

Consensus

Hold

Valuation

Fair Value

Similar

Bloomberg, BDN

DON'T BUY

Great company. Sold newspaper division at an opportune time. Has always been an expensive company. Their largest business is the markets side and that business has been suffering. Earnings growth is questionable at the present. Great management running a company in a tough industry. Dividend payout ratio is high.

PAST TOP PICK

Is going to be a bit challenged until the economy improves. Has share buy-back in place which looks good. Making management changes to the company to help with the execution.

COMMENT

Very high quality name that generally trades with the market. If you believe in a Santa Claus rally, like he does, it should participate fully in that.

HOLD

Really interesting at this point. Their business has not fallen that drastically. They are a beta for the financial markets and specifically track the bank indexes. Their financial products are highly sensitive to a cut in spending for a lot of the banks. However, they also have legal, medical and marketing data. Trading at 5X EBITDA versus their normal 7X.

SELL

Not a big fan of what you are getting here. You are not getting a fantastically or terrifically managed company.

DON'T BUY

Missed their earnings again but raised their dividends. He thought this was wrong so sold his holdings. Good dividend yield but has been struggling.

PAST TOP PICK

(A Top Pick Sept 9/10. Down 18.3%.) Still likes the company and the management but business has been a little rocky. Turnaround is slower than people expected. A long-term Hold.

PAST TOP PICK

(A Top Pick June 16/11. Down 13.68%.)

SELL

Into law information, market information and healthcare information. These are the first things that are cut in a struggling economy. Have struggled since acquiring writers. Trading at 20X earnings.

TOP PICK

Has disappointed. Went through cost cutting. Two weeks ago they announced more changes. Have increased dividend year after year after year. Decent margins. Sees dividend growth and with price under pressure it is the time to pickup the stock

HOLD

He is just below breakeven on this stock. Liked the valuation and merger with Reuters. New platform for the financial industry has had a slower uptake than expected. There has been a management shakeup in the last week. Getting down to being over sold. Dividend is very safe.

BUY

Got downgraded today. Since February it has not done particularly well. The news industry has not been doing well. News out of News Corp. has weighed on the industry. It’s getting down to be cheap. Thinks they will do very well.

PAST TOP PICK

(Top Pick Sep 9/10, Down 7.00%) What’s not working in the integration is taking longer than the market expected. The market doesn’t like it. Thinks it is the last quarter of the problems of the integration. Still adding for new clients.

SELL

1st rate company but are not executing as well as they might. If you own, consider moving to a stock that will be much more prolific. (See Top Picks.)

HOLD

Recent performance has been very disappointing. Merger with Reuters was a very good move but integration is not going as well as they would like. Also, Reuters has a lot of European exposure and this has been weighing on the share price. Well positioned to grow.

Showing 196 to 210 of 710 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)